Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

OPEC/Mpec for Adult T-Cell Leukemia/Lymphoma: A Single-Institution Study

Daisuke Nakamura, MD, PhD, Makoto Yoshimitsu, MD, PhD, Tomohisa Tabuchi, MD, Naosuke Arima, MD, Maiko Hayashida, MD, Hirosaka Inoue, MD, Kakushi Matsushita, MD, PhD, Tadashi Matsumoto, MD, PhD, Naomichi Arima, MD, PhD, Kenji Ishitsuka, MD, PhD

Blood (2016) 128 (22): 1828.

https://doi.org/10.1182/blood.V128.22.1828.1828

Published: 2016

Journal Articles

Immune Exhaustion and 2B4 Expression in Human T-Cell Lymphotropic Virus Type 1(HTLV-1) Infection

Ezinne Chioma Chibueze, MD, Yohann White, MD, PhD, Makoto Yoshimitsu, MD PhD, Tomohiro Kozako, PhD, Shinsuke Suzuki, MD, PhD, Kakushi Matsushita, MD, Kimiharu Uozumi, MD, PhD, Naomichi Arima, MD, PhD

Blood (2012) 120 (21): 4807.

https://doi.org/10.1182/blood.V120.21.4807.4807

Published: 2012

Journal Articles

Target Epitopes of Human T Lymphotropic Virus 1 Recognized by Class I MHC-Restricted Cytotoxic T Lymphocytes in HAM/TSP Patients and Infected Patients with Autoimmune Disorders.

Tomohiro Kozako, PhD, Masaki Akimoto, MD, PhD, Yohann White, MD, Shingo Toji, Kakushi Matsushita, MD, PhD, Ryuji Kubota, MD, PhD, Shuji Izumo, MD, PhD, Shinsuke Suzuki, MD, PhD, Kimiharu Uozumi, MD, Hiroshi Shimeno, PhD, Shinji Soeda, PhD, Naomichi Arima, MD, PhD

Blood (2009) 114 (22): 2660.

https://doi.org/10.1182/blood.V114.22.2660.2660

Published: 2009

Journal Articles

Increased Frequency of HTLV-1 Tax Specific CD8+ Regulatory T-Cells in HTLV-1 Infected Individuals.

Yohann White, MBBS, BMedSc, Makoto Yoshimitsu, MD, Tomohiro Kozako, PhD, Kakushi Matsushita, MD, PhD, Kimiharu Uozumi, MD, Shinsuke Suzuki, MD, PhD, Hiroki Kofune, BSc, Naomichi Arima, MD, PhD

Blood (2009) 114 (22): 3676.

https://doi.org/10.1182/blood.V114.22.3676.3676

Published: 2009

Journal Articles

Immunological Function against Human T-Lymphotrophic Virus Type I in Carriers with Collagen Diseases and HAM/TSP.

Tomohiro Kozako, PhD, Makoto Yoshimitsu, MD, Masaki Akimoto, MD, PhD, Kakushi Matsushita, MD, PhD, Yohann White, MD, Shingo Toji, Shuji Izumo, MD, PhD, Shunro Sonoda, MD, PhD, Naomichi Arima, MD, PhD

Blood (2008) 112 (11): 1470.

https://doi.org/10.1182/blood.V112.11.1470.1470

Published: 2008

Journal Articles

Soluble CD22 as a tumor marker for hairy cell leukemia

Kakushi Matsushita, Inger Margulies, Masanori Onda, Satoshi Nagata, Maryalice Stetler-Stevenson, Robert J. Kreitman

Blood (2008) 112 (6): 2272–2277.

https://doi.org/10.1182/blood-2008-01-131987

Published: 2008

Journal Articles

CTL Exhaustion in Persistent HTLV-1 Infection and ATLL Is Restored through PD-1/PD-L1 Pathway.

Tomohiro Kozako, PhD, Makoto Yoshimitsu, MD, Hiroshi Fujiwara, MD, PhD, Izumi Masamoto, MS, Sawako Horai, PhD, Masaki Akimoto, MD, PhD, Yukio Suruga, MD, PhD, Hideaki Kawada, MD, Heiichiro Hamada, MD, Noriko Aoki, MD, Shinsuke Suzuki, MD, PhD, Kakushi Matsushita, MD, PhD, Kimiharu Uozumi, MD, PhD, Chuwa Tei, MD, PhD, Naomichi Arima, MD, PhD

Blood (2007) 110 (11): 511.

https://doi.org/10.1182/blood.V110.11.511.511

Published: 2007

Journal Articles

A Pilot Study of Reduced-Intensity Conditioning Stem Cell Transplantation with T-Cell Replete HLA-Mismatched Allograft from Child to Parent Patient for the Treatment of Refractory Adult T-Cell Leukemia.

Hiroshi Fujiwara, MD, PhD, Atsuo Ozaki, MD, Makoto Yoshimitsu, MD, Heiichiro Hamada, MD, Hideaki Kawada, MD, Kakushi Matsushita, MD.Ph.D, Naomichi Arima, MD.Ph.D, Chuwa Tei, MD.Ph.D

Blood (2006) 108 (11): 5406.

https://doi.org/10.1182/blood.V108.11.5406.5406

Published: 2006

Journal Articles

The Frequency, Diversity, and Function of Human T-Cell Leukemia Virus Type 1-Specific CD8+ T-Cell Is Reduced in Adult T-Cell Leukemia Patients.

Tomohiro Kozako, PhD, Masaki Akimoto, MD, Izumi Masamoto, Makoto Yoshimitsu, MD, Kakushi Matsushita, MD, PhD, Shinsuke Suzuki, MD, PhD, Kimiharu Uozumi, MD, PhD, Naomichi Arima, MD, PhD

Blood (2006) 108 (11): 1264.

https://doi.org/10.1182/blood.V108.11.1264.1264

Published: 2006

Journal Articles

Soluble CD30 Can Distinguish Disease Progression from Acute GVHD in Patients with Adult T Cell Leukemia/Lymphoma Who Received Allogeneic Hematopoietic Stem Cell Transplantation.

Makoto Yoshimitsu, MD, Hiroshi Fujiwara, MD, PhD, Noriko Aoki, MD, Atsuo Ozaki, MD, Heiichiro Hamada, MD, Kakushi Matsushita, MD, Naomichi Arima, MD, Chuwa Tei, MD

Blood (2006) 108 (11): 4423.

https://doi.org/10.1182/blood.V108.11.4423.4423

Published: 2006

Journal Articles

Anti-HTLV-I Tax-Protein-Specific CTL Is Not Necessarily Resposible for Graft-v.s.-ATL Effect in Allogeneic SCT for Patients with Adult T-Cell Leukemia/Lymphoma.

Hiroshi Fujiwara, MD, PhD, Izumi Masamoto, Tomohiro Kozako, PhD, Hideaki Kawada, MD, Makoto Yoshimitsu, MD, Noriko Aoki, MD, Atsuo Ozaki, MD, Heiichiro Hamada, MD, Kakushi Matsushita, MDPhD, Naomichi Arima, MD, PhD, Chuwa Tei, MDPh.D

Blood (2005) 106 (11): 5353.

https://doi.org/10.1182/blood.V106.11.5353.5353

Published: 2005

NARROW

OPEC/Mpec for Adult T-Cell Leukemia/Lymphoma: A Single-Institution Study

Immune Exhaustion and 2B4 Expression in Human T-Cell Lymphotropic Virus Type 1(HTLV-1) Infection

Target Epitopes of Human T Lymphotropic Virus 1 Recognized by Class I MHC-Restricted Cytotoxic T Lymphocytes in HAM/TSP Patients and Infected Patients with Autoimmune Disorders.

Increased Frequency of HTLV-1 Tax Specific CD8+ Regulatory T-Cells in HTLV-1 Infected Individuals.

Immunological Function against Human T-Lymphotrophic Virus Type I in Carriers with Collagen Diseases and HAM/TSP.

Soluble CD22 as a tumor marker for hairy cell leukemia

CTL Exhaustion in Persistent HTLV-1 Infection and ATLL Is Restored through PD-1/PD-L1 Pathway.

A Pilot Study of Reduced-Intensity Conditioning Stem Cell Transplantation with T-Cell Replete HLA-Mismatched Allograft from Child to Parent Patient for the Treatment of Refractory Adult T-Cell Leukemia.

The Frequency, Diversity, and Function of Human T-Cell Leukemia Virus Type 1-Specific CD8+ T-Cell Is Reduced in Adult T-Cell Leukemia Patients.

Soluble CD30 Can Distinguish Disease Progression from Acute GVHD in Patients with Adult T Cell Leukemia/Lymphoma Who Received Allogeneic Hematopoietic Stem Cell Transplantation.

Anti-HTLV-I Tax-Protein-Specific CTL Is Not Necessarily Resposible for Graft-v.s.-ATL Effect in Allogeneic SCT for Patients with Adult T-Cell Leukemia/Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only